These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16206672)

  • 41. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy.
    De Carvalho JA; Piva SJ; Hausen BS; Bochi GV; Kaefer M; Coelho AC; Duarte MM; Moresco RN
    Clin Chim Acta; 2011 Jul; 412(15-16):1407-11. PubMed ID: 21527256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic performance of kidney injury molecule-1 for detection of abnormal urinary albumin-to-creatinine ratio in type 2 diabetes mellitus.
    Abdelraheem S; Ahmed N; Zahran FE; Mohammed G; Ibrahim ESI
    J Immunoassay Immunochem; 2021 Nov; 42(6):1954947. PubMed ID: 34355651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes.
    Narita T; Hosoba M; Kakei M; Ito S
    Diabetes Care; 2006 Jan; 29(1):142-4. PubMed ID: 16373913
    [No Abstract]   [Full Text] [Related]  

  • 47. Pitfalls of the urinary albumin creatinine ratio in detection of early diabetic kidney disease.
    Garrahy A; Tormey WP
    Ir Med J; 2015 Apr; 108(4):102-3. PubMed ID: 26016297
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of the diagnostic characteristics of urinary kidney injury molecule 1 (uKIM-1) and uKIM-1/creatinine ratio in the assessment of incipient diabetic kidney disease.
    De Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Torbitz VD; Guarda NS; De Campos LP; Duarte T; Duarte MM; Londero SW; Comim FV; Moresco RN
    Clin Chem Lab Med; 2015 Feb; 53(2):e51-4. PubMed ID: 25153602
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical significance of the detection of urinary albumin in diabetic patients].
    Wang ZL; Feng GB; Zhang YL
    Zhonghua Nei Ke Za Zhi; 1988 Mar; 27(3):139-42, 196. PubMed ID: 3219928
    [No Abstract]   [Full Text] [Related]  

  • 50. Increase in serum ceruloplasmin with aging is not observed in type 2 diabetes.
    Daimon M; Susa S; Hasegawa K; Yamaguchi H; Kimura M; Ohnuma H; Eguchi H; Igarashi M; Manaka H; Kato T
    Endocr J; 2000 Jun; 47(3):215-9. PubMed ID: 11036863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination effect of hypertension and diabetes mellitus on urinary protein excretion.
    Kawada T
    J Hypertens; 2014 Nov; 32(11):2277. PubMed ID: 25271915
    [No Abstract]   [Full Text] [Related]  

  • 52. Urinary markers of glomerular injury in diabetic nephropathy.
    Cohen-Bucay A; Viswanathan G
    Int J Nephrol; 2012; 2012():146987. PubMed ID: 22645683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes].
    Qin LX; Zeng X; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD; Zheng M; Zhao LL; Qian Y; Yao XM; Ren A; Li SM; Jing CY
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary leucine aminopeptidase is a more sensitive indicator of early renal damage in non-insulin-dependent diabetics than microalbuminuria.
    Bedir A; Ozener IC; Emerk K
    Nephron; 1996; 74(1):110-3. PubMed ID: 8883027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The clinical significance of detection of urinary ceruloplasmin in type 2 diabetes].
    Shi H; Fang J; Yang Y; Jiang W; Xie J; Li Y; Zhu X
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):823-5. PubMed ID: 16206672
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.